La malattia reumatica, oggi

Translated title of the contribution: Rheumatic fever, today

Mario Carrabba, M. G. Marrazza, F. Atzeni, G. Randisi

Research output: Contribution to journalArticle

Abstract

Acute rheumatic fever (ARF), once considered the most common rheumatic disease encountered in children and adoloscents, is a rare complicance of the pharingeal infection by group A streptococci. ARF is characterized by a latency of 2-3 weeks after the acute episode of pharingitis and is characterized by at least one of the three following symptoms: 1) migratory arthritis usually of the big joints at lower limbs; 2) carditis (pericarditis, myocarditis or endomiocarditis) accompanied by the clinical and laboratory exams; 3) Sydenham chorea involving the central nervous system. Cardiac involvement presents primarily as pericarditis; endocardial or valvular involvement is rare. The carditis is approximately observed in 65% to 91% of the patients. Although, the disease prevalence is greatly reduced in the Western countries (in 1980 an annual incidence ranging from 0,23 to 1,88/100.000 inhabitants/yearly was described), actually a significant increase is being observed expecially in the developing countries (in which 2/3 of the patiens live) with an estimate incidence of 10 to 20 millions of new cases every year. The rheumatic carditis represents the worst consequence after 10 to 20 years from the first attack of rheumatic fever. The mitralic disease as stenosis or stenoinsufficiency is the most frequent form followed by the aortic valve involvement. The use of modern diagnostic instruments (Doppler echocardiography) doesn't seem to modify significantly the process of diagnostic evaluation.

Original languageItalian
Pages (from-to)82-91
Number of pages10
JournalProgressi in Reumatologia
Volume3
Issue number1
Publication statusPublished - 2002

Fingerprint

Rheumatic Fever
Myocarditis
Pericarditis
Chorea
Doppler Echocardiography
Incidence
Streptococcus
Rheumatic Diseases
Aortic Valve
Developing Countries
Arthritis
Lower Extremity
Pathologic Constriction
Central Nervous System
Joints
Infection

ASJC Scopus subject areas

  • Rheumatology

Cite this

Carrabba, M., Marrazza, M. G., Atzeni, F., & Randisi, G. (2002). La malattia reumatica, oggi. Progressi in Reumatologia, 3(1), 82-91.

La malattia reumatica, oggi. / Carrabba, Mario; Marrazza, M. G.; Atzeni, F.; Randisi, G.

In: Progressi in Reumatologia, Vol. 3, No. 1, 2002, p. 82-91.

Research output: Contribution to journalArticle

Carrabba, M, Marrazza, MG, Atzeni, F & Randisi, G 2002, 'La malattia reumatica, oggi', Progressi in Reumatologia, vol. 3, no. 1, pp. 82-91.
Carrabba M, Marrazza MG, Atzeni F, Randisi G. La malattia reumatica, oggi. Progressi in Reumatologia. 2002;3(1):82-91.
Carrabba, Mario ; Marrazza, M. G. ; Atzeni, F. ; Randisi, G. / La malattia reumatica, oggi. In: Progressi in Reumatologia. 2002 ; Vol. 3, No. 1. pp. 82-91.
@article{de80dc54651c407ab7b6224230a482c7,
title = "La malattia reumatica, oggi",
abstract = "Acute rheumatic fever (ARF), once considered the most common rheumatic disease encountered in children and adoloscents, is a rare complicance of the pharingeal infection by group A streptococci. ARF is characterized by a latency of 2-3 weeks after the acute episode of pharingitis and is characterized by at least one of the three following symptoms: 1) migratory arthritis usually of the big joints at lower limbs; 2) carditis (pericarditis, myocarditis or endomiocarditis) accompanied by the clinical and laboratory exams; 3) Sydenham chorea involving the central nervous system. Cardiac involvement presents primarily as pericarditis; endocardial or valvular involvement is rare. The carditis is approximately observed in 65{\%} to 91{\%} of the patients. Although, the disease prevalence is greatly reduced in the Western countries (in 1980 an annual incidence ranging from 0,23 to 1,88/100.000 inhabitants/yearly was described), actually a significant increase is being observed expecially in the developing countries (in which 2/3 of the patiens live) with an estimate incidence of 10 to 20 millions of new cases every year. The rheumatic carditis represents the worst consequence after 10 to 20 years from the first attack of rheumatic fever. The mitralic disease as stenosis or stenoinsufficiency is the most frequent form followed by the aortic valve involvement. The use of modern diagnostic instruments (Doppler echocardiography) doesn't seem to modify significantly the process of diagnostic evaluation.",
keywords = "Carditis, Rheumatic fever",
author = "Mario Carrabba and Marrazza, {M. G.} and F. Atzeni and G. Randisi",
year = "2002",
language = "Italian",
volume = "3",
pages = "82--91",
journal = "Progressi in Reumatologia",
issn = "1129-8758",
publisher = "Mattioli 1885 S.p.A.",
number = "1",

}

TY - JOUR

T1 - La malattia reumatica, oggi

AU - Carrabba, Mario

AU - Marrazza, M. G.

AU - Atzeni, F.

AU - Randisi, G.

PY - 2002

Y1 - 2002

N2 - Acute rheumatic fever (ARF), once considered the most common rheumatic disease encountered in children and adoloscents, is a rare complicance of the pharingeal infection by group A streptococci. ARF is characterized by a latency of 2-3 weeks after the acute episode of pharingitis and is characterized by at least one of the three following symptoms: 1) migratory arthritis usually of the big joints at lower limbs; 2) carditis (pericarditis, myocarditis or endomiocarditis) accompanied by the clinical and laboratory exams; 3) Sydenham chorea involving the central nervous system. Cardiac involvement presents primarily as pericarditis; endocardial or valvular involvement is rare. The carditis is approximately observed in 65% to 91% of the patients. Although, the disease prevalence is greatly reduced in the Western countries (in 1980 an annual incidence ranging from 0,23 to 1,88/100.000 inhabitants/yearly was described), actually a significant increase is being observed expecially in the developing countries (in which 2/3 of the patiens live) with an estimate incidence of 10 to 20 millions of new cases every year. The rheumatic carditis represents the worst consequence after 10 to 20 years from the first attack of rheumatic fever. The mitralic disease as stenosis or stenoinsufficiency is the most frequent form followed by the aortic valve involvement. The use of modern diagnostic instruments (Doppler echocardiography) doesn't seem to modify significantly the process of diagnostic evaluation.

AB - Acute rheumatic fever (ARF), once considered the most common rheumatic disease encountered in children and adoloscents, is a rare complicance of the pharingeal infection by group A streptococci. ARF is characterized by a latency of 2-3 weeks after the acute episode of pharingitis and is characterized by at least one of the three following symptoms: 1) migratory arthritis usually of the big joints at lower limbs; 2) carditis (pericarditis, myocarditis or endomiocarditis) accompanied by the clinical and laboratory exams; 3) Sydenham chorea involving the central nervous system. Cardiac involvement presents primarily as pericarditis; endocardial or valvular involvement is rare. The carditis is approximately observed in 65% to 91% of the patients. Although, the disease prevalence is greatly reduced in the Western countries (in 1980 an annual incidence ranging from 0,23 to 1,88/100.000 inhabitants/yearly was described), actually a significant increase is being observed expecially in the developing countries (in which 2/3 of the patiens live) with an estimate incidence of 10 to 20 millions of new cases every year. The rheumatic carditis represents the worst consequence after 10 to 20 years from the first attack of rheumatic fever. The mitralic disease as stenosis or stenoinsufficiency is the most frequent form followed by the aortic valve involvement. The use of modern diagnostic instruments (Doppler echocardiography) doesn't seem to modify significantly the process of diagnostic evaluation.

KW - Carditis

KW - Rheumatic fever

UR - http://www.scopus.com/inward/record.url?scp=0142010685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142010685&partnerID=8YFLogxK

M3 - Articolo

VL - 3

SP - 82

EP - 91

JO - Progressi in Reumatologia

JF - Progressi in Reumatologia

SN - 1129-8758

IS - 1

ER -